Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2025-12-25 @ 5:35 PM
NCT ID:
NCT02069704
Group ID:
EG000
Title:
Bevacizumab Biosimilar (BEVZ92)
Description:
Bevacizumab biosimilar (BEVZ92): Bevacizumab biosimilar (BEVZ92), Active ingredient Bevacizumab 25 mg/mL (strength = 100mg/mL). 30-minute\* IV infusion (5 mg/kg) every 2 weeks, prior to chemotherapy (Folfox any or Folfiri).
Deaths Number Affected:
11
Deaths Number At Risk:
None
Serious Number Affected:
19
Serious Number At Risk:
69
Other Number Affected:
66
Other Number At Risk:
69
Study:
NCT02069704
Results Section:
NCT02069704
Adverse Events Module:
NCT02069704